Cited 0 times in
Clinical Application of 18F-FDG PET in Malignant Melanoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 윤, 준기 | - |
dc.date.accessioned | 2011-11-21T04:30:30Z | - |
dc.date.available | 2011-11-21T04:30:30Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1975-129X | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/4461 | - |
dc.description.abstract | 18F-FDG PET showed a high sensitivity and specificity in the initial staging of malignant melanoma, and it also
predicted the prognosis correctly. In addition, it had a higher sensitivity and specificity in the detection of recurrence and restaging than conventional imaging modalities. Meanwhile, there’s less clinical evidence to support the use of 18F-FDG PET in the response evaluation for chemotherapy and the diagnosis/differential diagnosis of malignant melanoma. | - |
dc.language.iso | ko | - |
dc.title | Clinical Application of 18F-FDG PET in Malignant Melanoma | - |
dc.title.alternative | 악성 흑색종에서 18F-FDG PET의 임상 이용 | - |
dc.type | Article | - |
dc.subject.keyword | 18F-FDG | - |
dc.subject.keyword | PET | - |
dc.subject.keyword | Malignant melanoma | - |
dc.contributor.affiliatedAuthor | 윤, 준기 | - |
dc.type.local | Journal Papers | - |
dc.citation.title | Nuclear medicine and molecular imaging | - |
dc.citation.volume | 42 | - |
dc.citation.number | suppl1 | - |
dc.citation.date | 2008 | - |
dc.citation.startPage | s140 | - |
dc.citation.endPage | s148 | - |
dc.identifier.bibliographicCitation | Nuclear medicine and molecular imaging, 42(suppl1). : s140-s148, 2008 | - |
dc.relation.journalid | J01975129X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.